Leisure sitting time associated with increased risk of cancer in women
the ONA take:
According to a study published in the journal Cancer Epidemiology, Biomarkers & Prevention, researchers have found that spending more leisure time sitting was associated with an increased risk for developing cancer in women.
For the study, researchers analyzed data from more than 146,000 men and women included in the American Cancer Society Cancer Prevention Study II Nutrition Cohort to compare leisure time sitting with cancer risk. Of the 77,462 women and 69,260 men, 12,236 women and 18,555 men were diagnosed with cancer between 1992 and 2009.
Results showed that leisure time sitting was associated with a 10% increased risk for developing cancer in women after adjusting for confounding factors, such as body mass index, physical activity, and other factors. Researchers found no association between sitting time and cancer risk in men.
The study demonstrated that sitting time was associated with an increased risk for developing invasive breast cancer, multiple myeloma, and ovarian cancer in women.
The authors note that further research is warranted to better understand the differences in associations of sitting time and cancer risk between men and women.
Researchers have found that spending more leisure time sitting was associated with an increased risk for developing cancer in women.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|